RPTR-147 in Patients With Selected Solid Tumors and Lymphomas
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03815682 |
Recruitment Status :
Terminated
(Development program terminated)
First Posted : January 24, 2019
Last Update Posted : December 6, 2022
|
Sponsor:
Repertoire Immune Medicines
Collaborator:
Merck Sharp & Dohme LLC
Information provided by (Responsible Party):
Repertoire Immune Medicines
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Terminated |
---|---|
Actual Primary Completion Date : | September 7, 2022 |
Actual Study Completion Date : | October 11, 2022 |